Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M38,722Revenue (TTM) $M4,860Net Margin (%)18.1Altman Z-Score11.2
Enterprise Value $M38,162EPS (TTM) $7.6Operating Margin %27.4Piotroski F-Score5
P/E(ttm)48.0Beneish M-Score-2.8Pre-tax Margin (%)27.4Higher ROA y-yN
Price/Book8.710-y EBITDA Growth Rate %--Quick Ratio2.2Cash flow > EarningsY
Price/Sales8.75-y EBITDA Growth Rate %--Current Ratio2.6Lower Leverage y-yY
Price/Free Cash Flow44.3y-y EBITDA Growth Rate %8.6ROA % (ttm)14.0Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)21.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M106ROIC % (ttm)25.9Gross Margin Increase y-yY

Gurus Latest Trades with REGN

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

REGN is held by these investors:



REGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Sanofi10% Owner 2017-01-11Buy87,298$369.71-0.15view
BAKER CHARLES ADirector 2016-12-12Sell3,000$392.02-5.84view
RYAN ARTHUR FDirector 2016-11-15Sell2,000$429.34-14.02view
GOLDSTEIN JOSEPH LDirector 2016-11-14Sell2,125$450-17.97view
GOLDSTEIN JOSEPH LDirector 2016-07-29Sell2,125$425-13.14view
Sanofi10% Owner 2016-06-14Buy64,731$363.861.45view
RYAN ARTHUR FDirector 2016-05-24Sell1,000$396.64-6.93view
Van Plew Daniel PEVP & General Mgr Industrial O 2016-05-18Sell4,413$385.77-4.31view
GOLDSTEIN JOSEPH LDirector 2016-04-06Sell2,000$425-13.14view
GOLDSTEIN JOSEPH LDirector 2016-03-21Sell2,000$375-1.56view

Quarterly/Annual Reports about REGN:

News about REGN:

Articles On GuruFocus.com
Manning & Napier’s Top 3 New Holdings Jan 26 2017 
A Green Light on Bayer Jan 19 2017 
Largest Insider Trades of the Week Jan 16 2017 
Take a Look at Sanofi Oct 05 2016 
3 of Frank Sands' Top 5 Transactions in 2nd Quarter Were Reductions Aug 14 2016 
Edward Owens Top 2nd Quarter Investments Aug 03 2016 
Frank Sands Sells Visa, Baidu, Alibaba May 24 2016 
Baron Funds Comments on Regeneron Pharmaceuticals May 23 2016 
Market-Beating Vanguard Health Care Fund Adds Shares to 5 Positions May 03 2016 
Vanguard Boosts Stake in Incyte in 1st Quarter May 02 2016 

More From Other Websites
[$$] DNA decoding initiative to involve 500,000 middle-aged Britons Mar 22 2017
GSK and Regeneron to mine gene data from 500,000 Britons Mar 22 2017
GSK and Regeneron to mine gene data from 500,000 Britons Mar 22 2017
U.K. Biobank, Regeneron and GSK Announce Largest Gene Sequencing Initiative on World's Most Detailed... Mar 22 2017
Sanofi-Genzyme files preemptive legal strike to protect eczema drug Mar 21 2017
Sanofi, Regeneron sue Amgen to protect eczema drug from patent claims Mar 21 2017
Amgen (AMGN): Repatha Outcomes Data Disappoint, Shares Drop Mar 20 2017
European Stocks Drift Lower; Deutsche Bank Falls on Rights Issue Details Mar 20 2017
European Stocks Set For Mixed Open: Dollar Slumps in Quiet Asia Trade Mar 20 2017
Amgen’s Repatha Study Shows Reduced Risk of Heart Attack, Stroke Mar 17 2017
Amgen's Repatha Study Shows Reduced Risk of Heart Attack, Stroke Mar 17 2017
The Biggest Loser: Amgen Drops 6.4% Mar 17 2017
Esperion's Dive On Amgen Heart Study 'Counterintuitive' On Pricing Mar 17 2017
CVS Health says Amgen data may increase eligible patients by millions Mar 17 2017
Express Scripts says Amgen data opens door to patients Mar 17 2017
Amgen Cholesterol Drug Cuts Risk of Heart Attack, Stroke but Not Enough to Quell Value Debate Mar 17 2017
Cholesterol drug cuts heart risks, spurs new debate on cost Mar 17 2017
Cholesterol drug cuts heart risks, spurs new debate on cost Mar 17 2017
What are Sanofi's (SNY) Strengths and Challenges in 2017? Mar 17 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)